Daiwa Securities Group Inc. Ascendis Pharma A/S Transaction History

Daiwa Securities Group Inc.

$27.1 Billion
Q2 2025

A detailed history of Daiwa Securities Group Inc. transactions in Ascendis Pharma A/S stock. As of the latest transaction made, Daiwa Securities Group Inc. holds 3,737 shares of ASND stock, worth $783,088. This represents 0.0% of its overall portfolio holdings.

Number of Shares

3,737

Previous 2,249 66.16%

Holding current value

$783,088

Previous $351,000 83.76%

% of portfolio

0.0%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	BUY	$137.41 - $179.1 $204,466 - $266,500	1,488 Added 66.16%	3,737 $645,000
Q4 2024 Feb 07, 2025	SELL	$122.0 - $146.6 $8,296 - $9,968	-68 Reduced 2.93%	2,249 $309,000
Q2 2024 Aug 07, 2024	SELL	$121.07 - $153.67 $19,613 - $24,894	-162 Reduced 6.53%	2,317 $316,000
Q1 2024 May 02, 2024	SELL	$123.45 - $159.4 $18,640 - $24,069	-151 Reduced 5.74%	2,479 $375,000
Q4 2023 Jan 31, 2024	SELL	$86.1 - $127.36 $10,676 - $15,792	-124 Reduced 4.5%	2,630 $331,000
Q3 2023 Nov 01, 2023	SELL	$86.5 - $103.97 $9,342 - $11,228	-108 Reduced 3.77%	2,754 $258,000
Q2 2023 Jul 31, 2023	SELL	$69.96 - $97.84 $6,786 - $9,490	-97 Reduced 3.28%	2,862 $255,000
Q1 2023 May 02, 2023	SELL	$104.9 - $126.78 $9,650 - $11,663	-92 Reduced 3.02%	2,959 $317,000
Q4 2022 Feb 06, 2023	BUY	$99.42 - $131.97 $2,883 - $3,827	29 Added 0.96%	3,051 $372,000
Q3 2022 Nov 02, 2022	SELL	$84.03 - $110.23 $6,386 - $8,377	-76 Reduced 2.45%	3,022 $312,000
Q2 2022 Aug 09, 2022	BUY	$78.08 - $117.61 $31,934 - $48,102	409 Added 15.21%	3,098 $288,000
Q1 2022 Apr 29, 2022	BUY	$102.18 - $135.75 $37,602 - $49,956	368 Added 15.86%	2,689 $316,000
Q4 2021 Feb 03, 2022	SELL	$127.1 - $169.66 $38,384 - $51,237	-302 Reduced 11.51%	2,321 $313,000
Q3 2021 Nov 05, 2021	BUY	$112.67 - $176.92 $47,884 - $75,191	425 Added 19.34%	2,623 $419,000
Q2 2021 Aug 06, 2021	SELL	$121.62 - $145.29 $38,188 - $45,621	-314 Reduced 12.5%	2,198 $290,000
Q1 2021 May 03, 2021	SELL	$124.92 - $173.33 $11,242 - $15,599	-90 Reduced 3.46%	2,512 $323,000
Q4 2020 Feb 04, 2021	BUY	$151.2 - $182.76 $353,505 - $427,292	2,338 Added 885.61%	2,602 $434,000
Q3 2020 Nov 02, 2020	BUY	$134.29 - $154.32 $671 - $771	5 Added 1.93%	264 $41,000
Q4 2019 Jan 31, 2020	SELL	$91.45 - $139.12 $2,926 - $4,451	-32 Reduced 11.0%	259 $36,000
Q3 2019 Nov 04, 2019	BUY	$95.8 - $118.9 $670 - $832	7 Added 2.46%	291 $28,000
Q2 2019 Jul 24, 2019	BUY	$107.11 - $132.09 $2,999 - $3,698	28 Added 10.94%	284 $33,000
Q1 2019 Apr 26, 2019	SELL	$62.15 - $129.99 $1,305 - $2,729	-21 Reduced 7.58%	256 $30,000
Q4 2018 Feb 05, 2019	BUY	$55.16 - $69.67 $5,516 - $6,967	100 Added 56.5%	277 $17,000
Q1 2018 May 02, 2018	BUY	$38.98 - $68.04 $6,899 - $12,043	177 New	177 $12,000

Others Institutions Holding ASND

# of Institutions

277

Shares Held

60M

Call Options Held

217K

Put Options Held

73.3K

View Full List

About Ascendis Pharma A/S

Ticker ASND
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,810,200
Market Cap $11.7B
Description
Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapeutics for unmet medical needs. The company offers SKYTROFA for treating patients with growth hormone deficiency (GHD). It also develops TransCon Growth Hormone (hGH) for pediatric GHD in Japan; TransCon hGH for adults with GHD; TransCon parathyroid hormone for adult h...

More about ASND

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Daiwa Securities Group Inc., based on Form 13F filings with the SEC.

News

Stay updated on Daiwa Securities Group Inc. with notifications on news.

Account

Daiwa Securities Group Inc. Ascendis Pharma A/S Transaction History